Citius Pharma Q1 EPS $(0.06) Down From $(0.02) YoY
Portfolio Pulse from Happy Mohamed
Citius Pharma (NASDAQ:CTXR) reported a Q1 EPS loss of $(0.06), a 200% increase in losses compared to $(0.02) per share from the same period last year.
February 14, 2024 | 10:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Citius Pharma reported a significant increase in its quarterly losses, with EPS at $(0.06) compared to $(0.02) from the same period last year.
The reported increase in losses for Citius Pharma is likely to negatively impact investor sentiment in the short term, as it indicates a worsening financial performance compared to the previous year.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100